Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?
Fukui
Hiroshi
H
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001201:Ascites / Q000188:drug therapy*; D005355:Fibrosis / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D017596:Renal Plasma Flow, Effective / Q000187:drug effects; D012964:Sodium / Q000652:urine
D000959:Antihypertensive Agents; D012964:Sodium; D019808:Losartan